Search Results (252)

Lower respiratory tract infections caused by Pseudomonas aeruginosa are a global concern. Patients with chronic lung diseases such as cystic fibrosis and non-cystic fibrosis bronchiectasis often do not receive adequate antibiotic delivery through conventional routes. P. aeruginosa employs several mechanisms, including biofilm formation and efflux pumps to limit the accumulation of bactericidal drug concentrations. Direct drug delivery to the lung epithelial lining fluid can increase antibiotic concentration and reduce treatment failure rates. This review discusses current research and developments in inhaled antibiotic formulations for treating P. aeruginosa infections. Recent studies on particle engineering for the dry powder inhalers of antibiotics emphasized three fundamental principles of development: micro, nano, and nano-in-microparticles. Carrier-free microparticles showed potential for high-dose delivery but suffered from poor aerosolization, which could be improved through a drug–drug combination. Amino acids in a co-spray-dried system improved powders’ aerodynamics and reduced moisture sensitivity while incorporating the chitosan/poly(lactic-co-glycolic acid) (PLGA)-modified release of the drug. Nano-in-microsystems, embedding lipid carriers, showed improved antibiofilm activity and controlled release. We also highlight emerging biologics, including antibacterial proteins/peptides, vaccines, bacteriophages, and probiotics. Research on antibiotics and biologics for inhalation suggests excellent safety profiles and encouraging efficacy for some formulations, including antimicrobial peptides and bacteriophage formulations. Further research on novel molecules and synergistic biologic combinations, supported by comprehensive animal lung safety investigations, will be required in future developments. Full article

The threats leading to the extinction of humanity accelerate the evolution and development of materials that are capable of providing conditions for preserving health and, implicitly, life. In our work, we developed drug delivery systems based on mesoporous silica which can deliver an antibiotic, bacitracin, in a more controlled manner. The synthesis of the FDU-12 was performed through a sol–gel method and alternatively functionalized with -NH₂ groups or with poly(N-acryloylmorpholine) chains. The loading of bacitracin was performed using the vacuum-assisted method we successfully used to load these mesoporous materials preferentially within the pores as proved by the TGA-DSC results. The release was performed in two types of simulated body fluid (SBF) and this process was evaluated with chromatographic method using UV detection. The obtained data were fitted in three mathematical models of kinetic drug release (Weibull model, Korsmeyer–Peppas model, and nonlinear regression). The antimicrobial evaluation demonstrated that bacitracin-loaded FDU-12 formulations exhibited strong activity against both reference and clinical Staphylococcus strains. At sub-inhibitory concentrations, all formulations significantly reduced microbial adherence and biofilm formation, although certain strain-dependent stimulatory effects were observed. Furthermore, exposure to sub-MIC levels modulated the production of soluble virulence factors (hemolysins, lipase, and amylase), in a formulation- and strain-dependent manner, underscoring the ability of surface-functionalized FDU-12 carriers to influence bacterial pathogenicity while enhancing antimicrobial efficacy. Full article

In response to the intermittent discharge and frequent flow interruptions characteristic of rural domestic wastewater, this study evaluated the treatment performance and microbial mechanisms of basalt fiber (BF) felt as a novel biofilm carrier, with comparative analyses against traditional polyurethane (PU) carrier. Under continuous-flow conditions, both carriers showed no significant difference in the removal efficiencies of COD and NH₄⁺-N. However, when switching to intermittent feeding mode with flow interruption, the BF reactor maintained high removal efficiencies for pollutants (COD, NH₄⁺-N and TN removals averaged 90.5%, 89.4% and 64.5%, respectively), significantly outperforming the PU reactor (COD, NH₄⁺-N and TN removals averaged 82.3%, 32.7% and 20.7%, respectively). High-throughput sequencing results revealed that the BF carrier significantly enriched nitrifiers (e.g., Nitrospira) and aerobic denitrifiers (e.g., Terrimonas and Bacillus) during the intermittent operation phase. Functional prediction further indicated increased abundances of functional genes associated with nitrification (amoA, hao), complete denitrification (narG, nosZ), as well as glycolysis (GAPDH) and the TCA cycle (IDH1, korA) related to NADH generation, suggesting an enhanced coupling mechanism of carbon and nitrogen metabolism in the BF system. Conversely, a significant reduction in microbial diversity and the abundance of relevant functional genes was observed on the traditional carriers. This study confirms that BF felt, serving as a biocarrier for rural domestic wastewater treatment, exhibits superior shock load resistance and nitrogen removal performance, which provides an efficient and reliable carrier option for decentralized wastewater treatment in rural areas. Full article

With accelerating urbanization, rivers have been severely polluted, resulting in widespread black and odorous waterways. The coagulation–sedimentation and contact oxidation bypass treatment process is characterized by low operational cost and simple operation and management. In this study, a coagulation–sedimentation–contact oxidation biofilter process was developed to treat heavily polluted malodorous blackwater. Among the tested biofilm carriers, rigid aramid fiber exhibited the fastest biofilm formation and the best pollutant removal performance. Based on a comprehensive evaluation of effluent quality and treatment capacity, the optimal operating conditions of the proposed process were identified as a PAC dosage of 50 mg/L, an air-to-water ratio of 7:1, and a hydraulic retention time (HRT) of 2 h. Under these conditions, the effluent concentrations of chemical oxygen demand (COD), ammonia nitrogen (NH₄⁺-N), and suspended solids (SSs) were consistently maintained below 30, 5, and 5 mg/L, respectively. Moreover, the optimized system demonstrated strong resistance to shock loading, maintaining stable operation at influent COD and SS concentrations of approximately 150 mg/L and 40 mg/L, respectively, while complying with the Class A Discharge Standard of Pollutants for Municipal Wastewater Treatment Plants. This study provides an efficient treatment strategy for malodorous blackwater remediation. Full article

Antimicrobial resistance (AMR) is escalating worldwide, posing a serious threat to global public health by driving infections that are no longer treatable with conventional antibiotics. CRISPR–Cas technology offers a programmable and highly specific therapeutic alternative by directly targeting the genetic determinants responsible for resistance. Various CRISPR systems can restore antibiotic susceptibility and induce selective bactericidal effects by eliminating resistance genes, disrupting biofilm formation, and inhibiting virulence pathways. Moreover, CRISPR can suppress horizontal gene transfer (HGT) by removing mobile genetic elements such as plasmids, thereby limiting the ecological spread of AMR across humans, animals, and the environment. Advances in delivery platforms—including conjugative plasmids, phagemids, and nanoparticle-based carriers—are expanding the translational potential of CRISPR-based antimicrobial strategies. Concurrent progress in Cas protein engineering, spatiotemporal activity regulation, and AI-driven optimization is expected to overcome current technical barriers. Collectively, these developments position CRISPR-based antimicrobials as next-generation precision therapeutics capable of treating refractory bacterial infections while simultaneously suppressing the dissemination of antibiotic resistance. Full article

Background/Objectives: Boron-dipyrromethene (BODIPY) derivatives are a superior class of fluorophores prized for their exceptional photostability and tunable photophysical properties. While ideal for imaging, their translation to photodynamic therapy (PDT) has been hampered by excitation in the visible range, leading to poor tissue penetration. To overcome this, intense research has focused on developing near-infrared (NIR)-absorbing BODIPY photosensitizers (PS). This review aims to systematically summarize the hierarchical design strategies, from molecular engineering to advanced nanoplatform construction, that underpin the recent progress of NIR-BODIPY PS in therapeutic applications. Methods: We conducted a comprehensive literature review using PubMed, Scopus, and Web of Science databases. The search focused on keywords such as “BODIPY”, “aza-BODIPY”, “near-infrared”, “photodynamic therapy”, “photothermal therapy”, “nanocarriers”, “hypoxia”, “immuno-phototherapy”, and “antibacterial.” This review analyzes key studies describing molecular design, chemical modification strategies (e.g., heavy-atom effect, π-extension), nanoplatform formulation, and therapeutic applications in vitro and in vivo. Results: Our analysis reveals a clear progression in design complexity. At the molecular level, we summarize strategies to enhance selectivity, including active targeting, designing “smart” PS responsive to the tumor microenvironment (TME) (e.g., hypoxia or low pH), and precise subcellular localization (e.g., mitochondria, lysosomes). We then detail the core chemical strategies for achieving NIR absorption and high singlet oxygen yield, including π-extension, the internal heavy-atom effect, and heavy-atom-free mechanisms (e.g., dimerization). The main body of the review categorizes the evolution of advanced theranostic nanoplatforms, including targeted systems, stimuli-responsive ‘smart’ systems, photo-immunotherapy (PIT) platforms inducing immunogenic cell death (ICD), hypoxia-overcoming systems, and synergistic chemo-phototherapy carriers. Finally, we highlight emerging applications beyond oncology, focusing on the use of NIR-BODIPY PS for antibacterial therapy and biofilm eradication. Conclusions: NIR-BODIPY photosensitizers are a highly versatile and powerful class of theranostic agents. The field is rapidly moving from simple molecules to sophisticated, multifunctional nanoplatforms designed to overcome key clinical hurdles like hypoxia, poor selectivity, and drug resistance. While challenges in scalability and clinical translation remain, the rational design strategies and expanding applications, including in infectious diseases, confirm that NIR-BODIPY derivatives will be foundational to the next generation of precision photomedicine. Full article

Wastewater-derived microplastics (WW-MPs) are increasingly recognised as reactive vectors for aromatic organic contaminants (AOCs), yet their role in contaminant fate remains insufficiently constrained. This review synthesises current knowledge on the transformation of microplastics in wastewater treatment plants, including fragmentation, oxidative ageing, additive leaching, and biofilm formation, and links these processes to changes in sorption capacity toward phenols, PAHs and their derivatives, and organochlorine pesticides (OCPs). We summarise the dominant adsorption mechanisms-hydrophobic partitioning, π-π interactions, hydrogen bonding, and electrostatic and, in some cases, halogen bonding-and critically evaluate how wastewater-relevant parameters (pH, ionic strength, dissolved organic matter, temperature, and biofilms) can modulate these interactions. Evidence in the literature consistently shows that ageing and biofouling enhance WW-MP affinity for many AOCs, reinforcing their function as mobile carriers. However, major gaps persist, including limited data on real wastewater-aged MPs, lack of methodological standardisation, and incomplete representation of ageing, competitive sorption, and non-equilibrium diffusion in existing isotherm and kinetic models. We propose key descriptors that should be incorporated into future sorption and fate frameworks and discuss how WW-MP-AOC interactions may influence ecological exposure, bioavailability, and risk assessment. This critical analysis supports more realistic predictions of AOC behaviour in wastewater environments. Full article

Background: Biofilm-associated infections remain a major challenge in modern medicine due to their high resistance to antibiotics and immune defences. Advances in materials science, chemistry, and nanotechnology have led to the development of innovative, non-antibiotic approaches to prevent or eradicate biofilms. Methods: This review summarises antibiofilm strategies reported between 2020 and 2025, grouped into chemical, enzymatic, physical–photonic, nanomaterial-based, and biological hybrid categories. Results: Chemical methods such as silver-based chemical systems, nitric oxide donors, and biosurfactants disrupt bacterial membranes, generate reactive oxygen species, and inhibit quorum sensing. Enzymatic coatings with DNase I or lysostaphin effectively reduce Staphylococcus aureus and S. epidermidis biofilms, showing stability after sterilisation and high biocompatibility. Physical–photonic techniques, including photocatalytic and light-activated coatings, provide controllable and renewable antibacterial activity. Nanomaterials such as silver nanomaterials, chitosan-based carriers, magnetic ferrites, and catalytic nanozymes enable targeted, ROS-mediated biofilm disruption. Biologically derived systems, including bacteriophage hydrogels and plant metabolites, offer eco-friendly, biocompatible alternatives. Conclusions: Recent antibiofilm innovations mark a transition from conventional antibiotics to multifunctional and adaptive systems integrating chemical, enzymatic, and physical mechanisms for effective biofilm control on medical surfaces. Full article

Cationic gemini surfactants, which constitute a unique class of amphiphilic molecules composed of two hydrophilic ammonium groups and two hydrocarbon tails connected by a spacer, have emerged as highly versatile functional agents with superior interfacial activity and self-assembly behavior compared to conventional monomeric analogs. Their structural tunability enables precise control over physicochemical properties, making them attractive for applications across diverse scientific and industrial domains. In biomedical sciences, gemini surfactants act as potent antimicrobial and anti-biofilm agents, as well as efficient carriers for drug and gene delivery. In nanotechnology and optoelectronics, they facilitate the synthesis and stabilization of nanoparticles, quantum dots, and perovskite nanocrystals, leading to improved colloidal stability, enhanced photophysical performance, and extended material lifetimes. Within the petroleum industry, gemini surfactants have proven effective in enhanced oil recovery (EOR) by reducing interfacial tension and in crude oil transportation as drag-reducing agents (DRAs), significantly lowering viscosity, turbulence, and pipeline energy losses. This review summarizes recent advances in the chemistry, mechanisms of action, and applications of gemini surfactants, highlighting their multifunctionality and emphasizing their potential in the development of next-generation sustainable technologies. Full article

Polymeric semiconductors have rapidly evolved from early conductive polymers, such as polyacetylene, to high-performance donor–acceptor copolymers, offering a unique combination of mechanical flexibility, solution processability, and tunable optoelectronic properties. These advancements have positioned polymeric semiconductors as versatile materials for next-generation electronics, including wearable, stretchable, and bio-integrated devices, IoT systems, and soft robotics. In this review, we systematically present the fundamental principles of polymeric semiconductors, including electronic structure, charge transport mechanisms, molecular packing, and solid-state morphology, and elucidate how these factors collectively govern device performance. We further discuss recent advances in synthesis strategies, thin-film processing techniques, molecular doping, and interface engineering, emphasizing their critical roles in improving operational stability, charge-carrier mobility, and energy efficiency. Key applications—such as organic photovoltaics, field-effect transistors, neuromorphic devices, and memristors—are analyzed, with a focus on the intricate structure–property–performance relationships that dictate functionality. Finally, we highlight emerging directions and scientific innovations, including sustainable and degradable polymers, hybrid and two-dimensional polymer systems, and novel strategies to enhance device stability and performance. By integrating fundamental polymer science with device engineering, this review provides a comprehensive, structured, and forward-looking perspective, identifying knowledge gaps and offering insights to guide future breakthroughs and the rational design of high-performance, multifunctional, and environmentally responsible polymeric electronic devices. Full article

Sodium alginate, a natural anionic polysaccharide, exhibits broad potential applications in food, biomedicine, and environmental engineering due to its favorable biocompatibility, degradability, and functional tunability. This review systematically summarizes its chemical structure, physicochemical characteristics, sources, and extraction methods. It also focused on modification strategies, including chemical approaches (e.g., esterification, oxidation, sulfation, graft copolymerization), physical methods (composite modification, irradiation cross-linking, ultrasound treatment), and biological (e.g., enzyme regulation), and elucidated their underlying mechanisms. In the context of food science, special emphasis is placed on food-compatible chemistries and mild modification routes (such as phenolic crosslinking, enzyme-assisted coupling, and other green reactions) that enable the development of edible films, coatings, and functional carriers, while distinguishing these from non-food-oriented chemical strategies. The review further highlights novel applications of modified sodium alginate in areas including food packaging, functional delivery systems, drug release, tissue engineering, and environmental remediation (heavy metal and dye removal). Overall, this work provides a comprehensive perspective linking modification pathways to food-relevant applications and clarifies how chemical tailoring of alginate contributes to the design of safe, sustainable, and high-performance bio-based materials. Full article

Antimicrobial resistance (AMR) is a present, pressing global public health crisis associated with rising morbidity and mortality rates due to previously curable infectious disease. Targeted drug delivery is an important approach to address AMR due to its ability to improve the therapeutic performance of antibiotics without leading to any adverse effects or organ toxicities. In this review we explore molecular mechanisms of AMR and drawbacks of conventional antibiotic therapies and discuss unique drug delivery approaches to compensate these. Nanoparticulate carrier systems, stimuli-responsive systems, antibody–drug conjugates, and CRISPR-Cas systems are some of the carrier method designs that are promising for tackling hard to treat infections related to pathogenic strains and biofilms due to their features. Many of these are among the most significant advances in the field. However, there are many challenges to be overcome, with biological limitations, scaling and regulatory challenges, etc., before they can be employed in commercial applications. Materials are being developed, and an approach standardized and applicable to future work is in development to improve the efficiency of targeted delivery systems. Controlled drug delivery, which could be the answer to an increasing AMR problem, will not only help in alerting awareness among individuals but will also help in prolonging the activity of antibiotics by providing synergistic interdisciplinary solutions. This review emphasizes the complementary role of targeted drug delivery in transitioning from laboratory investigations to clinical therapy. It addresses underrepresented aspects, including new materials, scalability, regulatory considerations, and ethical implications, while offering a roadmap for translating innovations into next-generation antimicrobials. Full article

Background/Objectives: Nanotherapies are a strategy to combat Candida resistance. This study analyzed the impacts of iron oxide nanoparticles (IONPs) functionalized with a chitosan (CS) layer acting as carriers of chlorhexidine (CHX) on an oral candidiasis microcosm biofilm. Methods: Saliva samples from three healthy donors were used to form biofilms, to which Candida species were added to reproduce an oral candidiasis microcosm. Biofilms were cultivated for 72 h on glass coverslips using an active adhesion model. Biofilms without Candida served as a control model. The nanocarrier loaded with CHX at 78 (IONPs-CS-CHX78) or 156 µg/mL (IONPs-CS-CHX156) was co-incubated with the biofilms for 24 h. Controls included isolated IONPs, CS, and CHX, in addition to an untreated group (NC). Assays for biomass production, metabolism, microbial load, and lactic acid production were conducted to assess antibiofilm effects. Biofilm structure, viability, and thickness were also examined by confocal microscopy. Statistical analysis was performed using one-way ANOVA or Kruskal–Wallis, subsequently accompanied by the Student–Newman–Keuls post hoc test (p < 0.05). Results: CHX and IONPs-CS-CHX156 were the most effective agents against all tested biofilm models, significantly reducing metabolism, microbial load (bacterial and fungal), and viability. For the oral candidiasis biofilm, the nanocarrier did not affect biomass or biofilm thickness but led to a significant increase in lactic acid levels compared to NC. Conclusions: It is concluded that the nanocarrier of CHX exhibits a significant reducing effect on oral candidiasis microcosm biofilms at half the concentration required for non-carried CHX. This nanostructure can be explored in the development of antiseptic or disinfectant solutions for managing oral candidiasis. Full article

Bacterial vaginosis (BV) is a highly prevalent vaginal infection characterized by a dysbiotic shift in the vaginal microbiota, with Gardnerella vaginalis acting as a principal pathogen. Despite its association with adverse reproductive outcomes, BV remains underexplored from both mechanistic and therapeutic standpoints. Standard antibiotic regimens frequently fail due to high recurrence rates driven by multidrug-resistant (MDR) G. vaginalis strains and biofilm formation. In response, natural compounds and nutraceuticals, owing to their intrinsic antibacterial, antibiofilm, and immunomodulatory properties, have emerged as promising candidates for alternative BV therapies. In this paper, we first compile and critically evaluate preclinical and clinical evidence on the efficacy of plant extracts, essential oils (EOs), probiotics, vitamins, proteins, fatty acids, and enzymes against G. vaginalis, emphasizing their mechanistic insights in restoring vaginal microbial balance. Next, we focus on the integration of these bioactive agents into engineered nanosystems, such as lipid-based nanoparticles (LNPs), polymeric carriers, and inorganic nanostructures, to overcome limitations related to solubility, stability, and targeted delivery. Nonetheless, comparative studies, combination therapies, and recent patent developments are discussed to highlight how naturally derived molecules can enhance antimicrobial potency and reduce cytotoxicity. In conclusion, these platforms demonstrate superior in vitro and in vivo efficacy, offering a paradigm shift in the management of BV. Key challenges include scalable manufacturing, regulatory approval, and comprehensive safety assessment. Future research should prioritize standardized nanoparticle (NP) synthesis, detailed pharmacokinetic and toxicity profiling, and well-designed clinical trials to validate nature-inspired, nanoengineered therapies against G. vaginalis-induced BV. Full article

This study aimed to evaluate the incorporation of graphene-based additives, graphene nanoplatelets (GNPs) and graphene oxide quantum dots (GOQDs), into polymeric fiber matrices used as biofilm supports in anaerobic digestion systems, determining additive specific effects by benchmarking the impregnated matrices against the same nylon carrier without additives under identical operational conditions. Modified matrices were assessed through BMP assays using the liquid fraction of fruit and vegetable waste (LF-FVW) as substrate. Intermediate GNP and GOQD loadings (FM50 and FMDOT50) achieved the highest methane yields (317.9 ± 20.2 and 348.4 ± 20.0 mL CH₄/g COD_(rem)) compared with the control fiber matrix (301.0 ± 20.1 mL CH₄/g COD_(rem)). Scanning electron microscopy (SEM) and Fourier transform infrared (FTIR) analyses confirmed nanomaterial retention on the matrix surface and interaction with microbial aggregates. Embedding the nanostructures within the fiber enhanced biofilm formation and methane yield while minimizing nanomaterial washout. Future work will focus on advanced physicochemical characterization (XRD, XPS, BET, and EDX mapping), leaching tests to assess long term stability, and scale up evaluation for full scale anaerobic digestion applications. Full article